Could This Cheap COVID Vaccine Spell Doom for Pfizer and Moderna?

Keith Speights and Brian Orelli, PhD, The Motley Fool
·4 min read

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) stand to make billions of dollars from their respective COVID-19 vaccines this year. In this Motley Fool Live video recorded on April 7, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether this cheap vaccine candidate might even spell doom for Pfizer and Moderna.